Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Therapeutics Company Awarded Patent For Breakthrough Liver Disease Treatment

Breakthrough in Liver Disease Treatment: Chemomab's CM-101 Secures New European Patent.
In the realm of medical science, groundbreaking advancements often mark pivotal moments in the fight against debilitating diseases. One such recent development in the battle against Primary Sclerosing Cholangitis (PSC), a rare and potentially fatal liver disease, has emerged from the labs of Chemomab Therapeutics. The company has been awarded a new European patent for CM-101, its first-in-class monoclonal antibody, now in Phase 2 clinical development for PSC. This news not only marks a significant milestone for Chemomab but also shines a beacon of hope for patients battling this challenging condition. $ $Chemomab Therapeutics(CMMB.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
2043 Views
Comment
Sign in to post a comment
    122Followers
    0Following
    280Visitors
    Follow